Clinical trial Recruiting at 1 site Interventional Ages 5 to 14

Effects of atropine eye drops on eye alignment and vision

Official title: The Effects of Atropine Eyedrops on Ocular Alignment and Binocular Vision

Run by Eye & ENT Hospital of Fudan University · NCT05379855 · Data updated 2026-11-12

This study is testing if low doses of atropine eye drops can help children aged 5 to 14 with eye alignment issues and myopia see better and slow down their vision problems.

Quick facts

Study typeInterventional
Ages5 Years to 14 Years
SexAll
Enrollment339 (estimated)
SponsorEye & ENT Hospital of Fudan University
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedMarch 2, 2024
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedFebruary 25, 2025
Trial IDNCT05379855 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 5 to 14 years with specific types of exotropia or myopia and no significant ocular or systemic health issues.

Probably not a fit

Patients with amblyopia or those with serious heart or respiratory diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of low concentration atropine eye drops on ocular alignment and binocular vision in children aged 5 to 14 years with conditions such as exotropia and myopia. Participants will be randomly assigned to receive either 0.01% or 0.05% atropine drops or a placebo, with the aim of assessing the efficacy of atropine in slowing myopia progression and improving eye alignment. The study will monitor changes in accommodation and ocular alignment over a specified period, contributing to understanding the long-term effects of atropine treatment.

Why it matters

Potential benefit: If successful, this treatment could significantly slow the progression of myopia and improve ocular alignment in affected children.

How similar studies have gone: Previous studies have shown promising results with low concentration atropine in managing myopia, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The age ranged from 5 to 14 years;
* Astigmatism \< 2.5D, spherical power: - 1.00D \~ -6.00D; difference between eyes in spherical power \< 1.5D, difference between eyes in astigmatism \< 1.00D;
* Intraocular pressure \< 21mmHg;
* Ocular alignment fulfilling the following criteria:Exophoria with an exodeviation at near \> 6PD12; Intermittent exotropia with an exodeviation ≤25 PD both at distance and at near, Titmus \<=400 arc seconds; Intermittent exotropia patients underwent strabismus surgery, 6 months after operation, fulling the criteria of exophoria and intermittent exotropia mentioned before.
* Subjects and their parents or legal guardians have signed informed consent and are willing to accept randomized grouping and regular follow-up.

Exclusion Criteria:

* Amblyopia
* Have heart disease or serious respiratory disease
* Allergic to atropine, cyclopentantone, propoxybenzocaine and benzalkonium chloride;
* Those who have used contact lenses, bifocal lenses, or other measures to control myopia (including atropine);
* No binocular vision;
* Combined with vertical strabismus≥5PD, abnormal oblique muscle function≥ 2+, cyclodeviation, DVD or A-V pattern, paralytic and restrictive strabismus, comitant esotropia;
* Previous history of other ocular surgery;
* Severe complications during or after strabismus surgery, such as perforation of the sclera, tear and detachment of extraocular muscle; postoperative eye movement limitation; visual acuity decreased after operation;
* Combined with other ocular diseases;
* Craniofacial malformations affecting the orbits;
* significant neurological disorders;
* Birth less than 34 weeks or birth weight less than 1500 g;
* Intraocular pressure \> 21mmhg;
* Unable to cooperate with the examination.

Where it's running

  • Eye and ENT Hospital, Fudan University
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.